Delivery Order SPE2DB24D2205-SPE2DB25FDWWK

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $79K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of XARELTO 20 MG TABLET 90S, a medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,956.05 and a performance period that ends on February 4, 2025. The contract is a Delivery Order placed under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at $999,999,999 and runs...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of XARELTO 20 MG TABLET 90S to the Defense Logistics Agency (DLA). The $30,784.46 Firm Fixed Price delivery order has a period of performance ending on July 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables efficient...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply XARELTO 20 MG TABLET 90S to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,785.80, is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that has a ceiling value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of essential pharmaceutical and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XARELTO 20 MG tablets. The contract has a ceiling value of $1,657.74 and a completion date of October 25, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
The federal government has awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XARELTO 20 MG TABLET 90S. The contract has a ceiling value of $8,332.30 and is set to run through December 13, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is an Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. This IDC serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XARELTO 20 MG TABLET 90S. The $5,192.68 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply XARELTO 20 MG TABLET 90S to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $57,220.12. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of XARELTO 20 MG TABLET 90S. The contract has a ceiling value of $40,532.45 and was awarded by the Defense Logistics Agency (DLA) on July 26, 2024, with a completion date of July 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of XARELTO 20 MG TABLET 90S. The contract has a ceiling value of $16,491.27 and a completion date of November 26, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $18,461.47 and an ultimate completion date of July 25, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. Amerisourcebergen holds a significant Indefinite Delivery...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDWWK
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, is for the delivery of XARELTO 20 MG TABLET 90S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $78,917.76 and a completion date of January 15, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation, awarded under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 10:31 AM